CONMED Corporation

Symbol: CNMD     Sector: Healthcare     Industry: Medical Devices

Dividend Yield
0.93%
Current Price
$85.82
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 18:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
218,378,000
218,378,000
96,940,000
121,438,000
109,801,000
11,637,000
1,021,000
390,709,000
1,760,837,000
1,067,780,000
693,057,000
23,407,000
14,385,000
23,407,000
817,940,000
6,084,000
-3,920,000
 
10,575,000

Financials 2018

Update: 2019-06-09 18:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
242,443,000
242,443,000
109,788,000
132,655,000
106,832,000
25,823,000
15,653,000
374,351,000
1,369,138,000
706,868,000
662,270,000
17,511,000
18,336,000
17,511,000
456,900,000
-11,698,000
24,703,000
 
10,371,000

Q 3

2018-09-30
202,307,000
202,307,000
91,680,000
110,627,000
99,105,000
11,522,000
5,825,000
363,462,000
1,362,980,000
710,324,000
652,656,000
29,691,000
18,045,000
29,691,000
460,945,000
6,348,000
4,351,000
 
14,122,000

Q 2

2018-06-30
212,820,000
212,820,000
96,549,000
116,271,000
99,589,000
16,682,000
8,719,000
347,400,000
1,363,732,000
715,540,000
648,192,000
23,401,000
16,951,000
23,401,000
449,187,000
3,336,000
20,625,000
 
9,985,000

Q 1

2018-03-31
202,064,000
202,064,000
92,507,000
109,557,000
92,279,000
17,278,000
10,657,000
342,378,000
1,350,034,000
707,406,000
642,628,000
21,131,000
15,793,000
21,131,000
458,201,000
-12,057,000
25,022,000
 
7,711,000

Financials 2017

Update: 2019-06-09 18:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
222,555,000
222,555,000
98,598,000
123,957,000
100,781,000
23,176,000
46,696,000
356,783,000
1,357,961,000
726,529,000
631,432,000
32,622,000
14,699,000
32,622,000
486,443,000
-11,525,000
20,812,000
 
8,378,000